Overview
Legal name
AURELIA BIOSCIENCE LTD
Region
East Midlands
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Aurelia Bioscience Ltd
Aurelia Bioscience Ltd is a UK company with status active founded in 2011 based in East Midlands.
CRN
07657187
Founded
2011
Age
14
Corporate ownership
Updated 06 Jun 2026 16:52
2 levels
1 ultimate controller
1
Company
Active
LTD
Aurelia Bioscience Ltd
CRN 07657187
2
Direct controller
Active
LTD
Charnwood Molecular Limited
CRN 03550782
3
Direct and ultimate controller
Active
LTD
W8S Directors Limited
CRN 14733769
4
Intermediate controller
Active
LTD
Maxwell Bidco Limited
CRN 12251742
Company events
Reference milestones and recent Companies House filing stream events.
6 events
20 Nov
2024
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQ0NDI3MDA2OWFkaXF6a2N4 | Paper/PDF filed
Published 22 Nov 2024 03:37
14 Nov
2024
Liquidation In Administration Proposals
InsolvencyAM03 | Transaction MzQ0MjY4MTQwNWFkaXF6a2N4 | Paper/PDF filed
Published 20 Nov 2024 10:54
08 Nov
2024
Liquidation In Administration Appointment Of Administrator
InsolvencyAM01 | Transaction MzQ0MTgyNjU1MmFkaXF6a2N4 | Paper/PDF filed
Published 09 Nov 2024 07:25
06 Sep
2024
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzNDc3OTk1MmFkaXF6a2N4
Published 06 Sep 2024 12:41
06 Sep
2024
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzNDc1ODk2OWFkaXF6a2N4
Published 06 Sep 2024 09:27
03 Jun
2011
Incorporated
InceptionCompany registered at Companies House
Public funding
1 award
First funded
2014
Funded years
2014
Age at first award
3 years
Projects
2014
Feasibility Studies
Lead participant
Development of phenotypic assays on novel 3-dimensional platforms for pharmacological profiling of compounds
1 Sep 2014 to 30 Jun 2016
Awarded
£112,450
Total cost £149,933
This project aims to develop novel phenotypic screening systems in which cells are grown in 3D in electrospun polymer microscaffolds in suspension and to evaluate this system with stem cells, recombinant cells and primary cells in a suite of model assays using luminescence, fluorescence and imaging readouts. Adherent cells in 3D could be manipulated as if...
Product types
Feasibility Studies